ACR Convergence 2025 Archives - Page 179 of 181

Abstract Number: 0446

A Balancing Act: The Interplay Between Resilience and Frailty in Rheumatoid Arthritis
Abstract Number: 0613

A Baseline Kidney Biopsy Is Not Always Feasible in Incident Lupus Nephritis: Insights From an Inception Cohort
Abstract Number: 2054

A Changing Paradigm: Reassessing the Role of Muscle Biopsy in Idiopathic Inflammatory Myopathies in a Single-Center Cohort
Abstract Number: 1287

A clear pattern of clinical presentation in juvenile systemic scleroderma is associated with interstitial lung disease
Abstract Number: 1668

A clinically validated assay for rapid determination of type I and type II interferon activity in pediatric inflammatory diseases
Abstract Number: 1406

A Combined Score of Facet Joint Ankylosis and Syndesmophyte Development Correlates Well with Spinal Mobility in Axial Spondyloarthritis
Abstract Number: 1405

A Combined Score of Syndesmophytes and Facet Joint Ankylosis Improves Sensitivity to Spinal Structural Damage Progression in Axial Spondyloarthritis
Abstract Number: 0719

A Combined Transcriptomics and Proteomics Approach to Identify Immune Signatures in ANCA-Associated Glomerulonephritis
Abstract Number: 1395

A Comparative Study of Yao Syndrome and Primary Sjögren’s Syndrome
Abstract Number: 1151

A Comparison of Patients with Cardiac Sarcoidosis vs. Other Systemic Manifestations of Sarcoidosis: A Retrospective Cohort Study
Abstract Number: 2389

A Comparison of Patients with Older Onset vs. Younger Onset SLE: A Retrospective Cohort Study
Abstract Number: 0309

A Composite Cumulative Cartilage Damage Metric Predicts Incident Symptomatic Knee OA: Data from the Osteoarthritis Initiative
Abstract Number: 1000

A Deep-Learning Based Approach Uncovers Novel Mediators of Micro-RNA Restraint of Type-2 Immunity
Abstract Number: 1626

A Delphi Exercise Informing the Development of Criteria to Measure Response to Treatment in Giant Cell Arteritis
Abstract Number: 2519

A Disproportionality Analysis of FDA Adverse Event Reporting System (FAERS) Events for Avacopan
Abstract Number: 1654

A Dual Inhibitor of TAK1 and MAP4K2, NG25, Suppresses Cytokine-Driven Inflammation in Juvenile Idiopathic Arthritis Synovial Fibroblasts
Abstract Number: 0886

A First-in-Class Biologic Selectively Targeting HLA-B27-Reactive T Cells in Ankylosing Spondylitis
Abstract Number: 1936

A Fully Automated Method for Measuring Minimum Tibiofemoral Joint Space Width in Knee Osteoarthritis Assessment: Data from the FNIH cohort
Abstract Number: 0915

A fusion of TACI variant and anti-IFNAR antibody with greater therapeutic effect on related autoimmune disease models
Abstract Number: 1135

A Gain-of-Function 5’UTR Variant in ANKH Causes Familial CPPD with Elevated Extracellular PPi and Citrate
Abstract Number: 0041

A genetically determined, serine-based and phosphorylation-dependent molecular switch regulates the inflammatory potential of human IgA
Abstract Number: 1468

A HIPAA-Compliant LLM for Personalized Therapeutic Decision-Making in Lupus Nephritis
Abstract Number: 0182

A Joint Effort: Implementing Depression Screening in a Safety-Net Rheumatology Clinic
Abstract Number: 0846

A Longitudinal Transcriptomic Study of Mycophenolate Mofetil in Systemic Sclerosis Skin with Clinical and Molecular Stratification
Abstract Number: 2396

A Machine Learning Algorithm Based on a 15-Autoantibody Profile by a Novel Fully Automated Multiplexed Microarray Immunoassay for the Diagnosis of Autoimmune Connective Tissue Diseases
Abstract Number: 0786

A Machine Learning Approach to Understand Age as a Risk Factor for Complications After Total Hip Arthroplasty
Abstract Number: 0467

A Machine Learning Classifier Leveraging Anti-RA33, Anti-PAD4, and Conventional Biomarkers Enhances Diagnostic Performance Characteristics for RA
Abstract Number: 2337

A Mediation Analysis of Tofacitinib’s Effects on SF-36: The Roles of Fatigue, Pain, Stiffness, and Mobility in Ankylosing Spondylitis
Abstract Number: 1869

A miRNA signature consisting of high Let7i-5p, high miR-483-5p, low miR-223- 3p characterizes connective tissue diseases with interstitial lung disease
Abstract Number: 0519

A Multi-criterion Feature Integration Framework for Accurate Diagnosis of Primary Sjögren’s Syndrome Using Routine Laboratory Tests: A Multicentre, Retrospective Cohort study
Abstract Number: 1696

A multi-omics resource of B cell activation reveals genetic mechanisms for autoimmune diseases
Abstract Number: 1609

A Multicenter Prospective Longitudinal Observational Study To Determine Safety Of Extended Treatment With Rituximab In Maintaining Remission In Patients With ANCA Associated Vasculitis (AAV) – An Interim Analysis
Abstract Number: 0263

A Multicenter Retrospective Case Series of Patients with Susac Syndrome treated with Rituximab
Abstract Number: 0221

A Multimodal Intervention Improves the Quantity and Quality of Disease Activity Measures Collection in a Multi-Centered National Rheumatoid Arthritis Network
Abstract Number: 1420

A Nationwide Analysis of In-Hospital Mortality in Adult Ankylosing Spondylitis
Abstract Number: 1740

A New Link Between Calprotectin, Cholesterol Efflux Dysfunction, and Premature Atherosclerosis in Juvenile Dermatomyositis
Abstract Number: 0902

A Novel Approach to study ANA+ B Cells in Lupus Integrating Flow Cytometry with Single-Cell culture
Abstract Number: 0029

A Novel B Cell Subpopulation Characteristic of IgA Vasculitis Identified by Single-Cell RNA Sequencing
Abstract Number: 1568

A Novel Endothelial Cell Profiling Assay to Identify Systemic Sclerosis Patient Characteristics at the Endothelial Cell Level
Abstract Number: 0911

A Novel FcRn × Albumin Bispecific Antibody Demonstrates Extended Half-life and Deep IgG Reduction in Preclinical Mouse Models
Abstract Number: 2204

A Novel Framework for Teratogenicity Counseling for Adolescents and Young Adults (AYAs) with Rheumatic Disease on Teratogenic Medications
Abstract Number: 0946

A Novel Preclinical Tool for Evaluating CD20 Antibody Efficacy Based on BAFF/CD20 Dual-target Humanized Mice
Abstract Number: 2155

A Novel TNFAIP3 Mutation Associated with Large Vessel Vasculitis: Expanding the Phenotypic Spectrum of A20 Haploinsufficiency
Abstract Number: 2011

A Phase 1 placebo controlled, single (SAD) and multiple dose escalation (MAD) safety and pharmacokinetic (PK) study of a novel colchicine analogue ABP-745 in healthy volunteers (HV)
Abstract Number: 0277

A Phase 1, Randomized Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Single and Multiple Ascending Doses and Food Effects of BGB-45035, a chimeric degradation activating compound (CDAC), in Healthy Participants
Abstract Number: 1674

A Phase 2, Randomized, Placebo-Controlled Trial of Hydroxychloroquine in Individuals At-Risk for Future Rheumatoid Arthritis
Abstract Number: 2012

A Phase 2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of ABP-671 in Subjects with Hyperuricemia or Gout in China
Abstract Number: 0473

A Phase 2b Dose-Ranging Study of Peresolimab for Adults with RA
Abstract Number: 1172

A Phase II, Single-Site, Open-Label Study of Zanubrutinib in Patients with IgG4-Related Disease
Abstract Number: 2181

A Pilot High-Fidelity Simulation for Pediatric Rheumatology Learners
Abstract Number: 2247

A Pilot Study to identify novel autoantibody biomarkers in Rheumatoid Arthritis (RA) patients using Immunome Protein Array
Abstract Number: 1731

A Post-Marketing Analysis of Autoimmune Toxicities Following Chimeric Antigen Receptor T-Cell Therapy Using the FDA Adverse Event Reporting System
Abstract Number: 2371

A Predictive Model Combining Clinical and Laboratory Parameters to Predict anti-TNF Response in Patients with Psoriatic Arthritis
Abstract Number: 0303

A Predictive Model for Liver Enzyme Elevations Based on Creatine Kinase in Idiopathic Inflammatory Myopathies
Abstract Number: 2697

A Prospective Randomized Controlled 96-week Study to Evaluate the Efficacy and Safety of Tacrolimus and Glucocorticoid as Continuous Induction-Maintenance Treatment for Class III/IV±V Lupus Nephritis
Abstract Number: 2053

A Prospective Study Unveils Damage Accrual and Myositis Specific Antibodies as Key Risk Factors for Mortality in Myositis
Abstract Number: 1133

A Proteomic Analysis Of Subclinical Synovial Inflammation Associated With Monosodium Urate Crystal Deposition
Abstract Number: 0037

A Proteomic Signature Containing TNF Receptor Superfamily Member 10A (TNFRSF10A) and Growth/Differentiation Factor 15 (GDF-15) Improves Prediction of All-Cause Mortality Among Individuals with Gout, Beyond Atherosclerotic Cardiovascular and Other Clinical Risk Factors
Abstract Number: 0231

A Quality Improvement Project to Explore the Implications of the 2020 ACR Gout Guideline Recommendations for HLA-B5801 Testing
Abstract Number: 1144

A quantitative study of renal medulla echogenicity in 250 Vietnames gout patients shows correlation with poor renal function
Abstract Number: 0692

A Randomised Open Label Pilot Trial Comparing Mycophenolate Mofetil with no Immunosuppression in Limited Cutaneous Systemic Sclerosis (MINIMISE-Pilot)
Abstract Number: 0114

A rare variant in the Extl3 gene is associated with altered Wnt signaling pathway in a novel mouse model of axial spondyloarthritis
Abstract Number: 0735

A Real-World Study from the Greater Paris Clinical Data Warehouse
Abstract Number: 1923

A Real-World Survey On Physicians’ Perspectives Of Uncontrolled Gout And Gout Management Practices.
Abstract Number: 0699

A Retrospective Comparison of Transplant Outcomes in Patients with and without Systemic Sclerosis
Abstract Number: 0698

A Retrospective Comparison of Transplant Outcomes with Different Induction Methods and Maintenance Prednisone in Systemic Sclerosis Patients
Abstract Number: 0209

A Retrospective Safety Analysis based on Platelets in Arthrocentesis and Joint injections in Cancer Patients
Abstract Number: 1122

A Retrospective Study of Adverse Cardiovascular Events in Patients Started on JAK Inhibitors at Two Major Health Systems in Northeast Ohio: Analysis of the 2019 JAK Inhibitors FDA Boxed Warning for Increased Risk of Serious Heart-Related Problems
Abstract Number: 2177

A Rheumatologic Ultrasound (RhUS) Educational Framework: Expert Consensus on RhUS Skills for Adult Rheumatology Fellows in the United States
Abstract Number: 1574

A rise in serum KL-6 levels predicts subsequent progressive pulmonary fibrosis in patients with systemic sclerosis-associated interstitial lung disease
Abstract Number: 0510

A risk estimation tool for clinical practice to improve early ILD detection in Sjögren Disease
Abstract Number: 2542

A Rule Based NLP Pipeline for Glucocorticoid exposure
Abstract Number: 0388

A Scoping Review of Outcomes of Adults With Childhood-Onset Systemic Autoimmune Rheumatic Diseases
Abstract Number: 1645

A sex-modified association between Perfluoroalkyl and Polyfluoroalkyl Substances (PFAS) blood concentration and prevalent arthritis among young and middle-aged US adults
Abstract Number: 0964

A Single-Cell Atlas Reveals Dermal Endothelial Heterogeneity and Disease-Specific Pathways in Autoimmune Disorders
Abstract Number: 0275

A snapshot of subcutaneous infliximab use in inflammatory rheumatic diseases: a multicenter Italian study
Abstract Number: 1376

A Systematic Literature Review on the Economic Burden of Sjögren’s Disease
Abstract Number: 1627

A systematic literature review to inform the 2025 EULAR recommendations for management of Polymyalgia Rheumatica and Large Vessel Vasculitis: management of disease including relapse and complications
Abstract Number: 1614

A Systematic Literature Review to Inform the EULAR Recommendations for the Management of Polymyalgia Rheumatica and Large Vessel Vasculitis: Focus on Referral and Diagnosis
Abstract Number: 0646

A-319, a CD3×CD19 T Cell Engager, for the Treatment of Refractory Systemic Lupus Erythematosus: Preliminary Evidence of Autoimmune Reset
Abstract Number: 1170

A20 Haploinsufficiency (HA20): TNFAIP3 Mutation Prevalence In A Clinically Compatible Cohort
Abstract Number: 0636

AA Novel Kidney-Specific Biomarker Panel Accurately Differentiates Lupus Nephritis from Diabetic Kidney Disease through Distinct Molecular Pathways Novel Kidney-Specific Biomarker Panel Accurately Differentiates Lupus Nephritis from Diabetic Kidney Disease through Distinct Molecular Pathways
Abstract Number: 1678

Abatacept in individuals at risk of developing rheumatoid arthritis: results from the Arthritis Prevention in the Pre-clinical Phase of RA with Abatacept Long Term Outcomes (ALTO) Study
Abstract Number: 2494

Abatacept Reduces CD319+ (SLAM-F7) Cytotoxic T Cells and Cytokine Production in Systemic Sclerosis
Abstract Number: 1124

ABCG2 Variants as Genetic Risk Factors for Hyperuricemia and Gout: Focus on Pediatric and Familial Manifestations
Abstract Number: 0097

Aberrant histone marks increase the inflammatory phenotype of rheumatoid arthritis fibroblast-like synoviocytes (RA FLS) by suppressing NUB1 induction
Abstract Number: 1655

Aberrant Noncoding RNAs Are Enriched in Extracellular Vesicles and Implicated in Interferon Activation
Abstract Number: 1022

Abuse in Rheumatic Diseases: Associations with Depression, Disability, and Psychosocial Risk Factors
Abstract Number: 1861

Accelerated and Gene-Specific Patterns of Clonal Hematopoiesis Distinguish Subtypes of Systemic Sclerosis
Abstract Number: 2570

Accelerometer-derived ‘weekend warrior’ physical activity, genetic susceptibility, and incident rheumatoid arthritis: a prospective cohort study
Abstract Number: 1007

Accelerometry-Derived Activity and Sleep Patterns in the NIH All of Us Cohort: Insights and Predictive Potential for Inflammatory Arthritis
Abstract Number: 1084

Access to rheumatology care in patients with new diagnosis of polymyalgia rheumatica: analysis from a national inception cohort
Abstract Number: 0645

Achievement of Low Disease Activity and Remission in Patients with Systemic Lupus Erythematosus Treated with Dapirolizumab Pegol: 48-Week Results from a Phase 3 Trial
Abstract Number: 2445

Achievement of Treat to Target Measures With Upadacitinib in Patients With Systemic Lupus Erythematosus: Phase 2 Randomized SLEek Clinical Trial Results
Abstract Number: 1349

Achievement of Treatment Targets and Maintenance of Response with Upadacitinib in Patients with Moderate-To-Severe Rheumatoid Arthritis in a Real-World Setting: Final 2-year Outcomes from the UPHOLD Study
Abstract Number: 1531

Achieving Remission and Low Disease Activity with Belimumab Versus Placebo in Patients with SLE Excluding the Glucocorticoid Component from Target Definitions: A Post Hoc Analysis of Five Phase 3 Trials
Abstract Number: 0801

Achieving Sustained Lupus Low Disease Activity State and Remission With Ianalumab (VAY736) in Patients with Systemic Lupus Erythematosus: A post hoc Analysis From a Phase II Study
Abstract Number: 2270

ACKR1 and Leukopenia in Patients with Rheumatoid Arthritis Treated with Disease Modifying Antirheumatic Drugs
Abstract Number: 0860

Activated protein C resistance and protein C antibodies in the antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository
Abstract Number: 1497

Acute Care Utilization in Patients with Antiphospholipid Syndrome and/or Systemic Lupus Erythematosus
Abstract Number: 0291

Acute onset inflammatory myositis: Clinical features and survival.
Abstract Number: 1739

Acute Transcriptomic Response of Synovium and Dorsal Root Ganglia to Joint Injury
Abstract Number: 2245

Add-on of Coronary Artery Calcium Score Significantly Improves the Risk Prediction of Cardiovascular Diseases in Patients with Rheumatoid Arthritis: From a Real-world Cohort Study
Abstract Number: 2176

Addressing Hesitancy in JAK Inhibitor Use: Outcomes from Continuing Medical Education Reveal Confidence-Knowledge Gaps Among Community Rheumatologists
Abstract Number: 1689

Addressing Perceived Discrimination in Lupus Care: Enhancing Patient Empowerment and Health Equity Through Education and Support
Abstract Number: 1916

Adherence to cervical cancer screening programs in women with Systemic Lupus Erythematosus
Abstract Number: 2201

Adherence to Reproductive Health Guidelines in Lupus Care: Insights from Patient and Physician Surveys
Abstract Number: 2206

Adolescents with Systemic Lupus Erythematosus at Highest Risk of Adverse Pregnancy Outcomes
Abstract Number: 0191

Advanced therapy use in RA patients with moderate disease activity in a large NHS Foundation Trust in South London, UK
Abstract Number: 1988

Advancing Vascular Assessment: Combining NIRS-VOT and Ultrasound-Based Brachial Artery Diameter for Improved Diagnostics in Healthy Controls and APS
Abstract Number: 1290

Adverse Childhood Experiences: Prevalence and Relationship to Disease and Mental Health Outcomes in Childhood-Onset Systemic Lupus Erythematosus (cSLE)
Abstract Number: 0744

Age and Sex Influence on Clinical Manifestations of Giant Cell Arteritis: Results from the ARTESER Registry
Abstract Number: 0607

Age at Diagnosis of SLE has Increased in a United States Longitudinal Cohort
Abstract Number: 1065

Age of Disease Onset and Risk of Serious Infection with anti-TNF Use in Older Adults with Rheumatoid Arthritis
Abstract Number: 2645

Age-specific Incidence of Systemic Lupus Erythematosus in the United States: A Meta-Analysis of Data from the Centers for Disease Control and Prevention Lupus Registries
Abstract Number: 0296

Aggregation of HARS1 and internalized antibodies in muscle biopsies of patients with antisynthetase syndrome and anti-Jo1(HARS) autoantibodies
Abstract Number: 2088

Aging Unevenly: National Trends and Inequities in Osteoarthritis Mortality, 1999–2020
Abstract Number: 2275

Agreement Between Two Rheumatoid Arthritis Response Measures Across b/ts DMARD Treatment Classes in a Large, Prospective Observational Study Supporting the Development and Clinical Validation of a Novel Blood-based Precision Medicine Test
Abstract Number: 1006

AI-Guided Generation and Preclinical Evaluation of an OX40L-IL31 Bispecific Antibody
Abstract Number: 0148

Air Pollution as a Trigger for Flares in Chronic Inflammatory Rheumatic Diseases: a Prospective Single-Center Study in the South of France
Abstract Number: 1013

All roads lead to Rheum? Modeling scenarios of new patients-to-pediatric rheumatologist ratios in different US states
Abstract Number: 2463

Allogenic anti- CD19 CAR-T cells induce remission in refractory systemic lupus erythematosus
Abstract Number: 2315

Alterations in the gut microbiome in ankylosing spondylitis and their correlation with disease activity
Abstract Number: 0894

Altered B cell subpopulations in Giant Cell Arteritis
Abstract Number: 0899

Altered B cell Subsets Shared in Immune Checkpoint Inhibitor Associated Sicca Syndrome and Sjogren’s Disease
Abstract Number: 0831

Altered expression of CD11c and HLA-DR on monocyte subsets in individuals at risk of rheumatoid and psoriatic arthritis
Abstract Number: 1700

Altered Gene Expression In Male SLE Is Mapped To a Male-Specific Y Chromosome Locus Associated with Microdeletions
Abstract Number: 0680

Altered miRNA patterns of peripheral blood mononuclear cells show correlations with pulmonary manifestations of systemic sclerosis
Abstract Number: 2597

Altered Tryptophan Metabolism in Neuropsychiatric Lupus: A Cluster Analysis to Identify Distinct Subgroups
Abstract Number: 1542

Alternative Definitions of Moderate Flares That Simulate Clinical Practice in Systemic Lupus Erythematosus: Post Hoc Exploration of Moderate Flares in Patients Treated with Dapirolizumab Pegol in a 48-Week Phase 3 Trial
Abstract Number: 2667

Amyloidosis Secondary to Familial Mediterranean Fever: Machine Learning Based Prediction Models
Abstract Number: 1942

An Agnostic Evaluation of Serum Proteins Discriminates the Severity of Ultrasound Arthritis in SLE Patients
Abstract Number: 0356

An Analysis of Osteoporosis Screening in Males 50 and Older with Rheumatic Disease across Stony Brook Medicine Network
Abstract Number: 0230

An Epic journey – Therapeutic Drug Monitoring at an Academic Center
Abstract Number: 0990

An Fc-engineered Agonistic Anti-PD-1 Antibody Selectively Depletes PD-1+ cells and Attenuates T cell activation in vitro and in vivo in a Xenogeneic Graft-versus-Host Disease (GvHD) model
Abstract Number: 2564

An illustration-based patient-reported outcome measure reveals concealed symptoms in patients with rheumatoid arthritis and the factor contributing to the discrepancy between patient and evaluator global assessments
Abstract Number: 0592

An Interim Analysis of Health-Related Quality of Life Outcomes from an International Multicentre Observational Study in Patients with Axial Spondyloarthritis Initiating Bimekizumab in Real-World Clinical Practice
Abstract Number: 0591

An Interim Analysis of Health-Related Quality of Life Outcomes from an International Multicentre Observational Study in Patients with Psoriatic Arthritis Initiating Bimekizumab in Real-World Clinical Practice
Abstract Number: 0389

An International Delphi Survey for the Definition of New Classification Criteria for Juvenile Idiopathic Arthritis
Abstract Number: 1178

An International modified Delphi Study on the evolving role of Janus kinase inhibitors (JAKi) in rheumatic and musculoskeletal diseases (RMDs)
Abstract Number: 0376

An Internet-Delivered, Arthritis-Tailored Cognitive Behavioral Therapy for Insomnia Program for People with Co-Morbid Sleep Disturbance: Comparing Baseline Characteristics of Cannabis Users and Non-Users
Abstract Number: 0471

An Open-label, Randomized, Controlled Phase 1/2 Study to Assess the Safety and Efficacy of KYV-101 Anti-CD19 CAR-T Cell Therapy in Active and Difficult-to-treat ACPA positive Rheumatoid Arthritis: Preliminary Results of the COMPARE Trial
Abstract Number: 2162

An Updated Needs Assessment for the Virtual Rheumatology Program for Fellows in Training (V-FIT)
Abstract Number: 0129

Analysis of Antiphosphatidylserine/prothrombin Antibodies as a Predictor of Lupus Anticoagulant in the Pediatric Population
Abstract Number: 2242

Analysis of Bronchoalveolar Fluid Cytokine Profile as a Way to Understand the Lung Disease Associated with Systemic Juvenile Idiopathic Arthritis
Abstract Number: 2395

Analysis of histopathological changes in the placenta of patients with systemic lupus erythematosus
Abstract Number: 1044

Analysis of Medicare and Medicaid Utilization and Expenditure of Newly Approved Biologics for Systemic Lupus Erythematosus Patients in the United States
Abstract Number: 1934

Analysis of the Determinants of Vaccine Acceptance and Hesitancy in Germany: A Mixed-Methods Approach Incorporating Health Insurance Data and Qualitative Interviews with Patients and Physicians
Abstract Number: 1274

Analysis of Vaccination Compliance In Patients With Juvenile Idiopathic Arthritis At The Rheumatology Transitional Consultation
Abstract Number: 2397

Analytical Performance of a Fully Automated Multiplexed Microarray Immunoassay for the Simultaneous Detection of Fifteen Autoantibodies Associated with Connective Tissue Diseases in a Reference Laboratory in Southern France
Abstract Number: 0711

Analytical Performance of a Novel, Fully Automated Multiplexed Microarray Immunoassay Prototype for the Simultaneous Detection of Autoantibodies to GBM, PR3, and MPO: A Multicenter Evaluation
Abstract Number: 2398

Analytical performance of the HEp-2 substrate Diagnostic Kit for ANA as an initial step in the evaluation of a novel Fully Automated IFA Analyzer in a laboratory in England
Abstract Number: 2120

Analyzing Gender and Racial Disparities in Paget’s Disease of Bone: A Large-Scale Observational Study
Abstract Number: 0729

ANCA-associated vasculitis – does the type matter?
Abstract Number: 0086

Androgen Upregulates Interferon Signaling in Osteoclast Differentiation During Inflammatory State
Abstract Number: 1436

Angiogenesis Markers in Difficult to Treat Psoriatic Arthritis Patients
Abstract Number: 0286

Anifrolumab For Treatment Of Refractory Juvenile Dermatomyositis In Adult Patients
Abstract Number: 1547

Anifrolumab In Systemic Lupus Erythematosus With Renal Involvement: National Multicenter Registry In Clinical Practice
Abstract Number: 1548

Anifrolumab In Systemic Lupus Erythematosus. Spanish Multicenter Registry In Clinical Practice
Abstract Number: 1428

Ankylosing Spondylitis Related Mortality Trends in USA from 1999-2020: Analysis of CDC Wonder Database
Abstract Number: 1331

Anti-beta-2-glycoprotein-1 IgA antibodies facilitate macrophage cholesterol loading and influence coronary atherosclerosis progression in a dose-dependent manner in rheumatoid arthritis
Abstract Number: 0647

Anti-CD19 Chimeric Antigen Receptor T Cell Therapy for Refractory Systemic Lupus Erythematosus: an open-label pilot study
Abstract Number: 0812

Anti-CD206 CAR T Cell Immunotherapy Mitigates Dermal Pathology in Systemic Sclerosis
Abstract Number: 1559

Anti-Cytolethal Distending Toxin Antibodies in Systemic Sclerosis: Associations with Gastrointestinal Disease and Immune Dysregulation
Abstract Number: 2417

Anti-dense fine speckled 70 antibodies in undefined disease, systemic autoimmune rheumatic diseases and controls
Abstract Number: 0281

Anti-IL-6 Autoantibodies and IL-6 Signalling in Idiopathic Inflammatory Myopathies
Abstract Number: 2652

Anti-mitochondrial antibodies in systemic sclerosis target enteric neurons and are associated with GI dysmotility
Abstract Number: 0529

Anti-PeptidylArginine Deiminase-2 (anti-PAD2) Autoantibodies in Psoriatic Arthritis
Abstract Number: 1219

Anti-Ro52 Antibody Identifies Patients with More Severe Lung disease among Patients with Idiopathic Inflammatory Myopathy
Abstract Number: 2386

Anti-Trim72 Auto-antibodies In Systemic Lupus Erythematosus Patients and a Lupus Mouse Model with Myocarditis Compromise Membrane Repair in Mouse & Human Cardiomyocytes
Abstract Number: 1512

Anti-U1-RNP Antibody Positivity is Associated with Elevated Interferon Score in SLE Irrespective of Disease Activity: A Transcriptome Analysis in Japanese Patients
Abstract Number: 1607

Antibiotic Prophylaxis during Treatment of ANCA-associated Vasculitis with Rituximab: Data from a Multicenter Cohort
Abstract Number: 0076

Antibodies to malondialdehyde-acetaldehyde are associated with circulating inflammatory mediators during the preclinical stages of rheumatoid arthritis
Abstract Number: 0631

Antibodies to Type I and Type III Interferons at Diagnosis Predispose to Serious Infections on Follow Up in an Inception cohort of SLE (INSPIRE) from India.
Abstract Number: 1162

Antineutrophil cytoplasmic antibody-associated isolated interstitial lung disease
Abstract Number: 1858

Antinuclear Antibodies from Systemic Sclerosis Patients Enter Cells via a Clathrin Endocytosis Mechanism and Interact with their Intracellular Antigen.
Abstract Number: 2391

Antinuclear Antibody Positivity in Patients with Psoriasis and Psoriatic Arthritis and the Risk of Developing Clinical Symptoms of SLE Following TNF Inhibitor Therapy
Abstract Number: 1188

Aortic Wall Shear Stress May Be a Protective Factor Against Development of Spinal Osteoproliferation
Abstract Number: 0897

APECED Disease Reorganizes The B Cell Compartment Toward Alternatively Activated Subsets
Abstract Number: 0528

Apolipoprotein A1 and B Levels Indicate Specific Lipid Changes In Early Treatment Naïve Psoriatic Arthritis and Correlate With 1-year Disease Activity
Abstract Number: 0109

Application of Psoriatic Arthritis Mouse Models in Preclinical Pharmacodynamic Evaluation
Abstract Number: 1351

Are Glucocorticoids Associated with Worse Overall Survival among Rheumatoid Arthritis Patients Treated with Immune Checkpoint Inhibitors? The Confounding Effect of Dexamethasone
Abstract Number: 1080

Are Minority Populations Truly Vaccine Hesitant? A Provider-Based Approach to RSV Vaccine Uptake Suggests Otherwise.
Abstract Number: 0117

Are Thrombotic or Obstetric Events Associated with Additional Clinical Domains in Triple Antiphospholypid Syndrome?
Abstract Number: 2283

Arrhythmia Risk in Diabetic Rheumatoid Arthritis Patients: Comparative Analysis of IL-6 Inhibitors versus TNF-α Inhibitors
Abstract Number: 1661

Artificial Intelligence applied to Patient Reported Outcomes and Passive Physiologic Sensor Data can Accurately Classify Low Disease Activity in Rheumatoid Arthritis Patients
Abstract Number: 0308

Artificial Intelligence Assisted Extraction of Patient-Reported Pain Outcomes in Osteoarthritis Using Prompt Engineering of Large Language Models
Abstract Number: 0177

Artificial intelligence in adult and paediatric rheumatology practice and research: pilot results from an international survey
Abstract Number: 0548

Artificial Intelligence in Axial Spondyloarthritis Diagnosis: Integrating Structural and Inflammatory Lesionsfrom Sacrum MRI
Abstract Number: 1210

Artificial Intelligence-Based Capillaroscopy and Laboratory Biomarkers to Predict Disease Activity in Idiopathic Inflammatory Myopathies: Preliminary Data from the CapIAMI Cohort
Abstract Number: 0569

ASAS recommendations on reporting outcomes of core outcome set instruments in axial spondyloarthritis clinical trials
Abstract Number: 2638

ASembleNet: A Hybrid AI Model for MRI-Based Classification of Ankylosing Spondylitis
Abstract Number: 0374

Assessing Attitudes and Barriers to Vaccination in Pediatric Rheumatic
Abstract Number: 0360

Assessing Content Validity of a New Questionnaire Evaluating Glucocorticoid Toxicity
Abstract Number: 1066

Assessing Disparities in Outcomes and Processes of Care for Patients with Juvenile Idiopathic Arthritis in the Pediatric Rheumatology Care and Outcomes Improvement Network
Abstract Number: 2685

Assessing for Racial/Ethnic Variability in U.S.-FRAXTM Performance Among Older Adult Women with Rheumatoid Arthritis in the United States
Abstract Number: 2565

Assessing Participation in the Lupus Sister Circle Support Group
Abstract Number: 1898

Assessing Representation in a Nation-Wide Psoriasis Registry: A Single-Institution Comparison
Abstract Number: 1708

Assessing Social Determinants of Health Using PRAPARE in a Rheumatology Patient Navigator Program for Underserved Brooklyn Communities
Abstract Number: 1966

Assessing the Impact of Cutaneous Melanin on Microvascular Oxygenation Measurement in Systemic Sclerosis Using Multispectral Imaging
Abstract Number: 2547

Assessing the Reach of a Virtual Education Program: Lupus & You: Answers. Advocacy. Action.
Abstract Number: 2271

Assessing the Real-World Impact of Earlier Initiation of Adalimumab vs. Conventional Synthetic DMARDs on Healthcare Resource Utilization in Patients with Rheumatoid Arthritis in Europe
Abstract Number: 1059

Assessing the Relationship Between Multidimensional Area Level Indicators and Lupus Disease Activity in Children
Abstract Number: 1895

Assessing the Validity of Self-Reported Medication Data Through Metabolite Analysis: Data from the Osteoarthritis Initiative
Abstract Number: 0363

Assessing Whole Health Needs in Systemic Lupus Erythematosus
Abstract Number: 1391

Assessment of Anti-SSA/Ro Testing Across Various Commercial Laboratories in the United States to Reduce the Burden of Surveillance in Pregnant Women with No History of Fetal Atrioventricular Block (fAVB)
Abstract Number: 0279

Assessment of Baseline IgG4-RD Disease Characteristics and Impact Upon Safety and Efficacy of Inebilizumab: Results from the MITIGATE Study
Abstract Number: 1154

Assessment Of Damage Using The IgG4-Related Disease Damage Index.
Abstract Number: 1422

Assessment of difficulties, modifications and use of work adaptations in patients with axial spondyloarthritis: validation of the DificuLtAx and ModAL questionnaires
Abstract Number: 1333

Assessment of lipid abnormalities after initiation of a JAK inhibitor in rheumatoid arthritis in clinical practice
Abstract Number: 0455

Assessment of Pain Outcomes in Pooled Phase 3 Trials of a Selective, Tyrosine Kinase 2 Inhibitor, Deucravacitinib, in Patients With Active Psoriatic Arthritis
Abstract Number: 2262

Assessment of small airway disease in rheumatoid arthritis
Abstract Number: 0604

Assessment of the Metabolic Score for Insulin Resistance (METS-IR) and Its Associated Factors in Patients with Systemic Lupus Erythematosus
Abstract Number: 1041

Associated Factors And Direct Cost Analysis Of Dose Reduction And Discontinuation Of Biological Therapies In Rheumatoid Arthritis And Spondyloarthritis: Findings From A Colombian Cohort Within The Framework Of An Integrated Management Model
Abstract Number: 0516

Association between anti-cytosolic 5′-nucleotidase 1A (anti-cN1A) antibodies and lymphoma in primary Sjögren Disease (SD)
Abstract Number: 1225

Association between Anxiety and Tender Swollen Joint Difference in Patients with Rheumatoid Arthritis
Abstract Number: 0758

Association Between Baseline IL-6 Levels and the Clinical Phenotype of Giant Cell Arteritis
Abstract Number: 0395

Association Between Body Mass Index (BMI) and JIA Inactive Disease at One Year
Abstract Number: 2591

Association Between Changes in Bone Quality Parameters and Inflammatory Ratios in Postmenopausal Women Treated With Romosozumab: A Retrospective Observational Study
Abstract Number: 0345

Association Between Deprivation and Fracture Risk in a Regional UK Cohort
Abstract Number: 0146

Association between frailty and delirium and hospitalization outcomes among older adults with rheumatic diseases
Abstract Number: 2252

Association between frailty and survival among older adults with rheumatoid arthritis and lung cancer
Abstract Number: 1016

Association between inflammatory biomarkers and predicted heart failure risk in rheumatoid arthritis
Abstract Number: 0387

Association Between Juvenile Arthritis and Physical Activity Levels in U.S. Children: A Cross-Sectional Study Using the 2016–2021 National Survey of Children’s Health
Abstract Number: 1128

Association between leptin levels, body mass index and health-related quality of life in patients with gout
Abstract Number: 0158

Association between newer COVID-19 vaccines and COVID-19 related hospitalizations among people with autoimmune rheumatic diseases in the U.S. National COVID Cohort Collaborative (N3C)
Abstract Number: 0443

Association between pan-immune-inflammation and synovitis as assessed by ultrasound in rheumatoid arthritis
Abstract Number: 1326

Association Between Physical Function and Nutritional Status in Rheumatoid Arthritis Patients
Abstract Number: 1249

Association between Positive Emotions and Physical Function in Early Rheumatoid Arthritis Patients
Abstract Number: 1105

Association between pre-existing rheumatoid arthritis and immune-related adverse events in patients with cancer receiving immune checkpoint inhibitors
Abstract Number: 1025

Association Between Rural-Urban Clinics and the Management of Adult Rheumatoid Arthritis in the United States
Abstract Number: 2366

Association Between Skin and Joint Symptom Control and Patient-Reported Pain and Health Status Among Patients with Psoriatic Arthritis in the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry Initiating Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs
Abstract Number: 1068

Association Between Social Determinants of Health Domains and COVID-19-Related Hospitalization in Individuals with Autoimmune Rheumatic Diseases: A Retrospective Analysis of National U.S. Data
Abstract Number: 1709

Association Between Social Risk Factors and Major Adverse Cardiovascular Events Among Individuals with Rheumatic Conditions
Abstract Number: 2079

Association Between Symptomatic Knee Osteoarthritis and Health-Related Quality of Life in Individuals with Type 2 Diabetes: A Cross-Sectional Study
Abstract Number: 0173

Association Between the Ratio of Non-High-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol and All-Cause Mortality Risk in Patients with Rheumatoid Arthritis: A Survival Analysis Based on NHANES Data
Abstract Number: 1557

Association between Thoracic Muscle and Fat Area and Density and Pulmonary Function in Systemic Sclerosis
Abstract Number: 1635

Association Between Treatment Adherence and Frailty in Patients with Rheumatic Diseases
Abstract Number: 0673

Association Between Vasoactive-Vasodilating Therapy and Reduced Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis: Evidence From a EUSTAR Study
Abstract Number: 2093

Association of Acetaminophen Use with Clinical Outcomes in Older Adults with Osteoarthritis: A Global Propensity-Matched Retrospective Cohort Analysis
Abstract Number: 1641

Association of Area Socioeconomic Deprivation with Community Mobility in a Diverse Cohort of Individuals with SLE
Abstract Number: 0708

Association Of Choroidal Sub-foveal Thickness With Skin Manifestations And Serum Monocyte HDL Ratio In Patients With Systemic Sclerosis-A Case Control Study
Abstract Number: 2254

Association of disease activity with insomnia, depression, and fatigue in patients with rheumatoid arthritis: a multicenter prospective observational study
Abstract Number: 1389

Association Of Dry Eye Severity With Salivary Flow In Patients With Primary Sjögren’s Syndrome
Abstract Number: 0691

Association of Elevated Platelets and CRP With Severe Disease and Poor Survival in Systemic Sclerosis
Abstract Number: 2325

Association of Galectin-3 and Myocardial Dysfunction in Patients with Psoriatic Arthritis
Abstract Number: 2683

Association of Genetic Risk for Pain Intensity with Longitudinal Disease Activity in Rheumatoid Arthritis
Abstract Number: 0046

Association of Genetic Variation in XIST and FTX with Susceptibility to Female-Biased Systemic Autoimmune Disease
Abstract Number: 0375

Association of Glucocorticoid Toxicity Index Scores with Quality-of-Life and Healthcare Resource Utilization at 6 Months in a Real-World Cohort of Individuals Receiving Glucocorticoids
Abstract Number: 1540

Association of Hypoalbuminemia with Serious Infections in Systemic Lupus Erythematosus Patients Receiving Dialysis
Abstract Number: 1590

Association of levels of soluble CD13 with clinical features and fibrosis in systemic sclerosis patients
Abstract Number: 0634

Association of Lifestyle and Integrative Health Practices with Health-Related Quality of Life in Women with Systemic Lupus Erythematosus and Connective Tissue Disease
Abstract Number: 2578

Association of Oral Outpatient Antiviral Medications for COVID-19 with the Risk of Post-Acute Sequelae of COVID-19 in Individuals with Systemic Autoimmune Rheumatic Diseases
Abstract Number: 1214

Association of Paraoxonase1 activity with Calcinosis in Patients with Scleroderma and Dermatomyositis : An exploratory analysis
Abstract Number: 0079

Association of Protein Arginine Deiminase 4 with the Myosin-9 Motor Complex
Abstract Number: 2286

Association of Semaglutide Prescription with Improved Joint Outcomes in Rheumatoid Arthritis Patients
Abstract Number: 0491

Association of Short Chain Fatty Acids and Diet with Disease Activity and Methotrexate Response in New Onset Rheumatoid Arthritis: A Proof of Principle Study
Abstract Number: 0602

Association of Systemic Lupus Erythematosus with Healthcare Resource Utilization and Healthcare Expenditures: Analysis of Nationally Representative Data, 2017-2022
Abstract Number: 1634

Association of Systemic Lupus Erythematosus With Incident Heart Failure Requiring Hospitalization
Abstract Number: 1565

Association of the gastrointestinal (GI) microbiome and GI symptoms in systemic sclerosis: An international, multi-center, observational study
Abstract Number: 0842

Association of urinary biomarkers with histological features in diagnostic and per-protocol repeat kidney biopsies in lupus nephritis
Abstract Number: 1146

Association of Walking Volume and Intensity With Incident Gout: A Population-based Cohort Study
Abstract Number: 2092

Associations Among Biomarkers, Cytokines, and Ultrasound Features of Knee Osteoarthritis: A Cross-Sectional Analysis in the Johnston County Health Study
Abstract Number: 1019

Associations Between Mental Health Diagnoses and Acute Care Use Among Individuals with Systemic Lupus Erythematosus in the All of Us Research Program
Abstract Number: 1100

Associations Between Pre-Existing Autoimmunity and CAR T Cell Therapy Toxicity for Cancer Treatment: A Nationwide Retrospective Cohort Study
Abstract Number: 1925

Associations between Representation and Quality in Clinical Trials for Systemic Lupus Erythematosus
Abstract Number: 2401

Associations between Serum Levels of Soluble Urokinase Plasminogen Activator Receptor (suPAR) and Activity and Chronicity Features in Diagnostic and Per-Protocol Repeat Kidney Biopsies in Patients with Lupus Nephritis
Abstract Number: 1705

Associations Between Social Risk Factors and Acute Care Use Among Patients with Rheumatic Conditions
Abstract Number: 0340

Associations with fragility fractures in a population with inflammatory bowel disease (IBD): An observational study.
Abstract Number: 0958

Asynchronous Resolution of Inflammation and Fibrosis in A Prolonged Experimental Model Suggests Distinct Temporal Dynamics And Resolution Mechanisms in Systemic Sclerosis
Abstract Number: 0477

At the patient level, ultrasound evaluation during the follow up of rheumatoid arthritis does not modify radiographic evolution: a prospective, multicenter, randomized, pragmatic clinical trial (BCD study)
Abstract Number: 1002

ATF3 Inhibits Pulmonary Fibrosis via CD4+CD25−LAG3+ T Cells
Abstract Number: 0001

ATG-201, a Novel Steric Hindrance-based Masking CD19xCD3 T-cell Engager (TCE) for the Treatment of B Cell-related Autoimmune Diseases
Abstract Number: 2636

Autoantibodies to 14-3-3 eta: A Novel Diagnostic Biomarker for Axial Spondyloarthritis
Abstract Number: 0617

Autoantibodies to Extracellular Antigens in Lupus Patients Serum Versus Controls; Predominance of Autoantibodies to Type I Interferons in Lupus Sera
Abstract Number: 2414

Autoantibody Clusters and SIGLEC1 are Predictive of Systemic Lupus Erythematosus Development
Abstract Number: 2059

Autoantibody Patterns in Myositis Immunoblot Testing: A Retrospective Study inInflammatory Myopathies and Connective Tissue Diseases (2017–2023)
Abstract Number: 2492

Autoantibody Profiles and Disease Trajectories in Early Systemic Sclerosis: Insights from a Prospective Cohort
Abstract Number: 2295

Autoantibody Profiles and Their Association with Organ Involvement in Primary Sjögren’s Syndrome: Insights from ESSDAI
Abstract Number: 2382

Autoimmune Hemolytic Anemia in SLE: A Real-World National Cohort Study
Abstract Number: 1476

Autoimmune Hemolytic Anemia in Systemic Lupus Erythematosus: A Meta-Analysis of Prevalence and Clinical Correlates
Abstract Number: 0250

Autoinflammatory diseases in adult patients. Spanish registry.
Abstract Number: 0323

Automated Effusion-Synovitis Volume is Prognostic and Responsive to Knee Osteoarthritis Progression: Data from the Osteoarthritis Initiative
Abstract Number: 2471

Automated Feedback and Quality Control in Nailfold Capillaroscopy: A Tool for Clinical and Educational Use
Abstract Number: 2612

Automated, Artificial Intelligence-supported Sonographic Examination of the Hands for the Detection and Quantification of Arthritis and Osteoarthritis in the Hand and Finger Joints in Outpatient Rheumatology Care
Abstract Number: 2172

Automating the Curation and Summarization of Rheumatology Fellowship Applications using Generative AI Agents and Transformer Models
Abstract Number: 2505

Avacopan is Not Associated With An Increased Risk of Infection Compared to Glucocorticoids in Patients with ANCA-Associated Vasculitis
Abstract Number: 2213

Awareness Regarding Contraceptive Measures, Drug Usage And Factors Affecting Pregnancy Among Patients With Autoimmune Rheumatic Diseases
Abstract Number: 1753

Axial Psoriatic Arthritis is Phenocopied in a Humanized Mouse Model
Abstract Number: 1374

AZD1163, a Novel Bispecific Human Antibody Targeting PAD2/4 Enzymes Responsible for Generating Citrullinated Protein Auto-antigens in Rheumatoid Arthritis, Demonstrates Dose-dependent Inhibition of Systemic PAD Activity in Healthy Volunteers